Drugmaker Teva to move listing to NYSE from Nasdaq
March 21 (Reuters) - Teva Pharmaceutical Industries Ltd , the world's largest generic drugmaker, said on Wednesday it plans to move its U.S.-listed shares to the New York Stock Exchange from the Nasdaq.
The Israel-based company expects its American Depositary Shares to begin trading on the NYSE on May 30 under its current stock symbol, "TEVA". Teva shares also trade on the Tel Aviv Stock Exchange.
Teva Chairman Phillip Frost said in a statement that the NYSE would "provide a state-of-the-art trading platform, as well as greater market reach."
- Sweden gets two new sightings, as hunt for undersea intruder goes on
- NOAA employee charged with stealing U.S. dam information
- Special Report: Traffickers use abductions, prison ships to feed Asian slave trade
- Hong Kong protesters plan march after fruitless talks with government
- Three Denver girls reportedly en route to Turkey detained, sent home